PHVS Stock Analysis: Buy, Sell, or Hold?
PHVS - Pharvaris N.V. Ordinary Shares
$30.40
-0.30 (-0.98%)
▼
5d:
+1.03%
30d:
+5.63%
90d:
+14.93%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Accumulation
PHVS is down 5.2% this week, but smart money is accumulating calls. Top strike: $22.5 2026-06-18 with 475 OI. Call ratio: 100% View Scanner →
Strength: 7.6/10
Get Alerted When PHVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PHVS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: PHVS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: PHVS is currently trading at $30.40, which is considered slightly high relative to its 30-day fair value range of $28.04 to $30.71.
Technical Outlook: Technically, PHVS is in a uptrend. Immediate support is located at $29.03, while resistance sits at $33.33.
Market Sentiment: PHVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.57 (+53.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHVS is in a uptrend. Immediate support is located at $29.03, while resistance sits at $33.33.
Market Sentiment: PHVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.57 (+53.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$28.04 -
$30.71
Company Quality Score
61/100
(BUY)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Options fairly priced (IV 32th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.2% below Wall St target ($46.57)
Trading Range Analysis
30-Day Trading Range
$28.04 -
$30.71
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$3.06
(10.1%)
Support & Resistance Levels
Support Level
$29.03
Resistance Level
$33.33
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.69
Wall Street Target
$46.57
(+53.2%)
Share & Embed Analysis
Last updated: May 18, 2026 9:23 AM ET
Data refreshes hourly during market hours. Next update: 10:23 AM
Data refreshes hourly during market hours. Next update: 10:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Anne Lesage
SELL
100 shares
2026-04-23
Johannes Gerardus Chri S…
SELL
100 shares
2026-04-23
Peng Lu
SELL
100 shares
2026-04-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 60 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$181 | 61 BUY |
Advanced PHVS Option Strategies
Professional options setups generated by AI based on today's PHVS price and gamma walls.
